Fed. Circ. Clears Apotex In Neulasta Biosimilar Patent Row
The appeals court said Judge James I. Cohn in the Southern District of Florida did not err when he ruled in September 2016 that Apotex’s copycat versions of Neulasta and Neupogen did not infringe Amgen’s patent.
Amgen raised various issues on appeal,...
To view the full article, register now.